{"transactions":[{"id":4620285,"issuer":{"id":3500,"kind":"organization","name":"Krystal Biotech, Inc.","symbol":"KRYS"},"owners":[{"id":40814,"kind":"person","name":"Mazzacco Catherine","position":1,"cik":"0001967722","reported_name":"Mazzacco Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-09-17T00:02:16.000Z","date":"2026-09-14","kind":"grant","planned":false,"acquired":true,"shares":471,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest in full on September 14, 2027, subject to continued service on the Company's Board of Directors through such date and to earlier vesting in certain circumstances described in the Company's Non-Employee Director Compensation Policy as in effect on the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest in full on September 14, 2027, subject to continued service on the Company's Board of Directors through such date and to earlier vesting in certain circumstances described in the Company's Non-Employee Director Compensation Policy as in effect on the date of grant."}],"balance_after":471,"derivative":{"underlying":"Common Stock","underlying_shares":471},"source":{"system":"sec-edgar","filing":"0001967722-26-000002","document":"wk-form4_1789603333.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1967722/000196772226000002/wk-form4_1789603333.xml","form_type":"4"}},{"id":4620284,"issuer":{"id":3500,"kind":"organization","name":"Krystal Biotech, Inc.","symbol":"KRYS"},"owners":[{"id":40814,"kind":"person","name":"Mazzacco Catherine","position":1,"cik":"0001967722","reported_name":"Mazzacco Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-17T00:02:16.000Z","date":"2026-09-14","kind":"grant","planned":false,"acquired":true,"shares":1187,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vest in full on September 14, 2027, subject to continued service on the Company's Board of Directors through such date and to earlier vesting in certain circumstances described in the Company's Non-Employee Director Compensation Policy as in effect on the date of grant."}],"balance_after":1187,"derivative":{"exercise_price":340.03,"expiration_date":"2036-09-13","underlying":"Common Stock","underlying_shares":1187},"source":{"system":"sec-edgar","filing":"0001967722-26-000002","document":"wk-form4_1789603333.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1967722/000196772226000002/wk-form4_1789603333.xml","form_type":"4"}},{"id":747535,"issuer":{"id":5537,"kind":"organization","name":"Sight Sciences, Inc.","symbol":"SGHT"},"owners":[{"id":40814,"kind":"person","name":"Mazzacco Catherine","position":1,"cik":"0001967722","reported_name":"Mazzacco Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-05T20:09:08.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":28261,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted stock units (\"RSUs\") made to the Reporting Person under the Issuer's Non-Employee Director Compensation Program. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share (\"Common Stock\"). The number of RSUs granted is equal to approximately $130,000 of shares of Common Stock as determined by the closing price on the grant date, June 4, 2026. The RSUs vest on the earlier of June 4, 2027 and the date of the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's continued service as a director on the Company's board of directors through such vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes (i) 30,952 shares of Common Stock, (ii) 28,261 RSUs which are subject to vesting as reported herein, and (iii) 10,063 RSUs granted to the Reporting Person on June 8, 2023 which are subject to vesting as previously reported."}],"balance_after":69276,"source":{"system":"sec-edgar","filing":"0001193125-26-259557","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1531177/000119312526259557/ownership.xml","form_type":"4"}},{"id":1040148,"issuer":{"id":5537,"kind":"organization","name":"Sight Sciences, Inc.","symbol":"SGHT"},"owners":[{"id":40814,"kind":"person","name":"Mazzacco Catherine","position":1,"cik":"0001967722","reported_name":"Mazzacco Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-15T21:28:07.000Z","date":"2025-09-11","kind":"gift","planned":false,"acquired":false,"shares":37492,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On September 11, 2025, the Reporting Person transferred the shares to the Catherine Mazzacco Irrevocable Trust DTD 10/23/2023 (the \"Trust\"), of which the Reporting Person is a beneficiary, for no consideration."}],"balance_after":41015,"source":{"system":"sec-edgar","filing":"0001193125-25-203807","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1531177/000119312525203807/ownership.xml","form_type":"4"}},{"id":1099291,"issuer":{"id":3500,"kind":"organization","name":"Krystal Biotech, Inc.","symbol":"KRYS"},"owners":[{"id":40814,"kind":"person","name":"Mazzacco Catherine","position":1,"cik":"0001967722","reported_name":"Mazzacco Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-30T21:59:03.000Z","date":"2025-06-30","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were awarded on June 30, 2025 and vest in equal monthly tranches over a one-year period."}],"balance_after":5000,"derivative":{"exercise_price":137.46,"expiration_date":"2035-06-30","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001967722-25-000002","document":"wk-form4_1751320735.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1711279/000196772225000002/wk-form4_1751320735.xml","form_type":"4"}},{"id":1116025,"issuer":{"id":5537,"kind":"organization","name":"Sight Sciences, Inc.","symbol":"SGHT"},"owners":[{"id":40814,"kind":"person","name":"Mazzacco Catherine","position":1,"cik":"0001967722","reported_name":"Mazzacco Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-11T01:32:33.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":30952,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted stock units (\"RSUs\") made to the Reporting Person under the Issuer's Non-Employee Director Compensation Program. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share (\"Common Stock\"). The number of RSUs granted is equal to approximately $130,000 of shares of Common Stock as determined by the closing price on the grant date, June 5, 2025. The RSUs vest on the earlier of June 5, 2026 and the date of the Issuer's 2026 annual meeting of stockholders, subject to the Reporting Person's continued service as a director on the Company's board of directors through such vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes (i) 37,492 shares of Common Stock, (ii) 30,952 RSUs which are subject to vesting as reported herein, and (iii) 10,063 RSUs granted to the Reporting Person on June 8, 2023 which are subject to vesting as previously reported."}],"balance_after":78507,"source":{"system":"sec-edgar","filing":"0000950170-25-084609","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1531177/000095017025084609/ownership.xml","form_type":"4"}},{"id":1465829,"issuer":{"id":3500,"kind":"organization","name":"Krystal Biotech, Inc.","symbol":"KRYS"},"owners":[{"id":40814,"kind":"person","name":"Mazzacco Catherine","position":1,"cik":"0001967722","reported_name":"Mazzacco Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-07-01T23:29:09.000Z","date":"2024-06-30","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were awarded on June 30, 2024 and vest in equal monthly tranches over a one-year period."}],"balance_after":5000,"derivative":{"exercise_price":183.64,"expiration_date":"2034-06-30","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001967722-24-000003","document":"wk-form4_1719876543.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1711279/000196772224000003/wk-form4_1719876543.xml","form_type":"4"}},{"id":1484531,"issuer":{"id":5537,"kind":"organization","name":"Sight Sciences, Inc.","symbol":"SGHT"},"owners":[{"id":40814,"kind":"person","name":"Mazzacco Catherine","position":1,"cik":"0001967722","reported_name":"Mazzacco Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-10T23:35:19.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":17366,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted stock units (\"RSUs\") made to the Reporting Person under the Issuer's Non-Employee Director Compensation Program. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share (\"Common Stock\"). The number of RSUs granted is equal to $120,000 divided by the closing price of the Common Stock on the grant date, June 6, 2024. The RSUs vest on the earlier of June 6, 2025 and the date of the Issuer's 2025 annual meeting of stockholders, subject to the Reporting Person's continued service as a director on the Company's board of directors through such vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes (i) 10,063 shares of Common Stock, (ii) 17,366 RSUs, which are subject to vesting as reported herein, and (iii) 20,126 RSUs granted to the Reporting Person on June 8, 2023, which are subject to vesting as previously reported."}],"balance_after":47555,"source":{"system":"sec-edgar","filing":"0000950170-24-071525","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1531177/000095017024071525/ownership.xml","form_type":"4"}},{"id":1839354,"issuer":{"id":5537,"kind":"organization","name":"Sight Sciences, Inc.","symbol":"SGHT"},"owners":[{"id":40814,"kind":"person","name":"Mazzacco Catherine","position":1,"cik":"0001967722","reported_name":"Mazzacco Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-07-03T22:04:04.000Z","date":"2023-06-08","kind":"grant","planned":false,"acquired":true,"shares":30189,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a grant of restricted stock units (\"RSUs\") made to the Reporting Person under the Issuer's Non-Employee Director Compensation Program. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share (\"Common Stock\"). The number of RSUs granted is equal to approximately $240,000 of shares of Common Stock as determined by the closing price on the grant date, June 8, 2023. The RSUs vest in substantially equal installments on each of June 8, 2024, 2025, and 2026, subject to the Reporting Person's continued service as a director on the Company's board of directors through each such vesting date."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-23-016838","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1531177/000089924323016838/doc4.xml","form_type":"4"}},{"id":1839756,"issuer":{"id":3500,"kind":"organization","name":"Krystal Biotech, Inc.","symbol":"KRYS"},"owners":[{"id":40814,"kind":"person","name":"Mazzacco Catherine","position":1,"cik":"0001967722","reported_name":"Mazzacco Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-07-03T20:35:23.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":2180,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were awarded on June 30, 2023 and vest in equal monthly tranches over a one-year period."}],"balance_after":2180,"derivative":{"exercise_price":117.4,"expiration_date":"2033-06-30","underlying":"Common Stock","underlying_shares":2180},"source":{"system":"sec-edgar","filing":"0001711279-23-000059","document":"wk-form4_1688416510.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1711279/000171127923000059/wk-form4_1688416510.xml","form_type":"4"}},{"id":1928423,"issuer":{"id":3500,"kind":"organization","name":"Krystal Biotech, Inc.","symbol":"KRYS"},"owners":[{"id":40814,"kind":"person","name":"Mazzacco Catherine","position":1,"cik":"0001967722","reported_name":"Mazzacco Catherine","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-04T21:05:48.000Z","date":"2023-03-31","kind":"grant","planned":false,"acquired":true,"shares":13600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were awarded on March 31, 2023 and vest in equal monthly tranches over a three-year period."}],"balance_after":13600,"derivative":{"exercise_price":80.06,"expiration_date":"2033-03-31","underlying":"Common Stock","underlying_shares":13600},"source":{"system":"sec-edgar","filing":"0001967722-23-000007","document":"wf-form4_168064231771350.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1711279/000196772223000007/wf-form4_168064231771350.xml","form_type":"4"}}]}